FMO5 and diabetic kidney disease: In diabetic kidney disease, hyperglycemia induces excessive ROS through activation of NADPH oxidases, mitochondrial dysfunction, and the advanced glycation end products/receptor for AGEs (AGE–RAGE) pathway.